← Back to Search

Asthma Management Program for Childhood Asthma

N/A

Recruiting

Led By Marina Reznik, MD, MS

Research Sponsored by Montefiore Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Mild persistent or more severe asthma, or asthma that is uncontrolled despite therapy

Parent is able to speak and understand either English or Spanish

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-12 months

Awards & highlights

Study Summary

This trial will test whether a school-based intervention that addresses key barriers to physical activity can reduce asthma morbidity among children with asthma.

Who is the study for?

This trial is for children in kindergarten to 5th grade with physician-diagnosed asthma, attending Bronx schools. They must have mild persistent or more severe asthma and be able to participate in physical activities. Caregivers must consent and speak English or Spanish. Children with other significant medical conditions, involved in another asthma study, or unable to stay in the area for 6 months are excluded.Check my eligibility

What is being tested?

The Asthma-PASS program aims to reduce barriers to physical activity (PA) for urban schoolchildren with asthma by providing a multifaceted intervention that includes education sessions on managing asthma effectively and promoting increased PA as part of their treatment plan.See study design

What are the potential side effects?

Since this trial focuses on educational interventions and increasing physical activity rather than medication, there are no direct side effects like those associated with drugs. However, increased PA could potentially lead to an increase in short-term asthma symptoms if not managed properly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My asthma is persistent or severe, or not controlled by my current treatment.

Select...

I can speak and understand either English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Symptom free days

Secondary outcome measures

Physical activity

Other outcome measures

Adherence

Asthma knowledge

Asthma self-management questionnaire

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Asthma-PASS InterventionExperimental Treatment2 Interventions

Collaboration with PCPs to optimize management. Community Health Worker (CHW) to ensure PCP plan is followed. Two asthma education sessions with children/caregivers focusing on self-efficacy and physical activity promotion. Promotion of asthma awareness in school. School personnel training in asthma

Group II: Asthma Management Comparison GroupActive Control2 Interventions

Includes two sessions of basic asthma education and PCP notification of child's asthma severity level.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,837 Previous Clinical Trials

47,851,211 Total Patients Enrolled

6 Trials studying Childhood Asthma

2,086 Patients Enrolled for Childhood Asthma

Montefiore Medical CenterLead Sponsor

442 Previous Clinical Trials

582,110 Total Patients Enrolled

1 Trials studying Childhood Asthma

530 Patients Enrolled for Childhood Asthma

University of RochesterOTHER

840 Previous Clinical Trials

534,178 Total Patients Enrolled

Media Library

Asthma-PASS Clinical Trial Eligibility Overview. Trial Name: NCT04576442 — N/A

Childhood Asthma Research Study Groups: Asthma-PASS Intervention, Asthma Management Comparison Group

Childhood Asthma Clinical Trial 2023: Asthma-PASS Highlights & Side Effects. Trial Name: NCT04576442 — N/A

Asthma-PASS 2023 Treatment Timeline for Medical Study. Trial Name: NCT04576442 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project grant access to participants of 40 years or older?

"This trial has set the minimum age to enroll at 5 years old and capped the upper limit of eligibility at 11."

Answered by AI

Can I qualify to be a contributor in this investigation?

"This medical trial is seeking 416 participants who are aged between five and eleven years old, with a diagnosis of asthma."

Answered by AI

What is the recruitment size for this research project?

"Correct. Information hosted on clinicaltrials.gov reports that recruitments for this medical trial, which was initially posted on February 9th 2021, are still ongoing. 416 patients need to be enrolled from a single location."

Answered by AI

What are the current enrollment criteria of this trial?

"According to the clinicaltrials.gov listing, this study is presently seeking participants. It was initially publicized on February 9th 2021 and most recently updated on January 14th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)

2021. "Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04576442.